Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

This upcoming quarter needs to be more than 10% higher than the last. I think this is possible based on the idea/hope that the Prasco sales in Dec were just a small part of the full sales made to Prasco for any given quarter. Meaning that I am optimistic that shipments to Prasco made from Jan to Mar could be double or triple whatever the Dec shipment was. I think it is safe to assume the Dec shipment wasn't very large given we saw only a 10% increase in revenue (not shabby but not enough to keep investors excited in an OTC stock). Without a 20% to 30% boost in revenue ($18 to $20 million) we will stay in the 11 to 13 cent range. Yes, I'm guessing another 5.5 months (3.5 months until 10Q w/o then another 1.5 months until next Q1) news that this could go down the 11s....

In Q3 CC I see that our working capital should start increasing at a faster clip. That would not be as impactful for short term increases but should provide more stability on the share price. The longer term OTC investor takes working capital seriously and it is certainly a tangible value that can't be argued with when a company is up for sale (which we know Elite will be in the relative near-term). The following is an explanation that Carter gave

Sales are strong, profits are increasing, but also on the flip side, inventory and receivables are also growing. Those two together grew almost $18 million for us. Whenever you have this type of growth, it takes in our industry, approximately nine to 12 months for these receivables and inventories to start rotating into positive cash flow. We have to buy the inventory, manufacture, sell it, ship it, collect our accounts receivable. So there's a whole process.

And roughly, it takes nine to 12 months, before what I call rotations happening, and we start achieving positive cash flows. And we are now nine months into that, and we're just entering that phase. So as we continue to grow, I look for the inventory and the receivables from the prior period, things that we already booked to start generating working capital, and that working capital will support the ongoing revenue expansion.